ORIGINAL ARTICLE
Angiotensin-converting enzyme insertion/deletion gene polymorphism and Henoch-Schonlein purpura nephritis risk in children: a meta-analysis
1
Department of Paediatrics, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei Province, China
Submission date: 2022-12-06
Final revision date: 2023-03-12
Acceptance date: 2023-03-14
Publication date: 2023-04-27
Corresponding author
Pan Yan
Department of Paediatrics The First Affiliated Hospital of Yangtze University Jingzhou, Hubei Province, China
Department of Paediatrics The First Affiliated Hospital of Yangtze University Jingzhou, Hubei Province, China
Pol J Pathol 2023;74(1):29-35
KEYWORDS
TOPICS
ABSTRACT
It has been demonstrated in many studies that angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is related to Henoch-Schonlein purpura nephritis (HSPN) risk in children. However, this conclusion remains controversial.
In this study, we systemically retrieved relevant studies in electronic databases such as PUBMED, CNKI, and EMBASE followed by calculation of odds ratios (OR) with 95% confidence intervals (CI). In addition, meta-package in STATA version 12.0 was used. Angiotensin-converting enzyme I/D polymorphism was related to HSPN susceptibility in children (D vs. I: OR 1.47, 95% CI: 1.13–1.93; DD vs. II: OR 2.29, 95% CI: 1.29–4.07; DI vs. II: OR 1.10, 95% CI: 0.82–1.48; dominant model: OR 1.44, 95% CI: 1.09–1.89; recessive model: OR 2.26, 95% CI: 1.67–3.06).
In addition, subgroup analysis stratified according to ethnicity indicated a significant relationship between this polymorphism and HSPN susceptibility among Asians and Caucasians. The data extracted from HaploReg indicated that ACE I/D polymorphism was not in linkage disequilibrium with other variants in the ACE gene.
The research shows that ACE I/D polymorphism is related to HSPN susceptibility in children.
In this study, we systemically retrieved relevant studies in electronic databases such as PUBMED, CNKI, and EMBASE followed by calculation of odds ratios (OR) with 95% confidence intervals (CI). In addition, meta-package in STATA version 12.0 was used. Angiotensin-converting enzyme I/D polymorphism was related to HSPN susceptibility in children (D vs. I: OR 1.47, 95% CI: 1.13–1.93; DD vs. II: OR 2.29, 95% CI: 1.29–4.07; DI vs. II: OR 1.10, 95% CI: 0.82–1.48; dominant model: OR 1.44, 95% CI: 1.09–1.89; recessive model: OR 2.26, 95% CI: 1.67–3.06).
In addition, subgroup analysis stratified according to ethnicity indicated a significant relationship between this polymorphism and HSPN susceptibility among Asians and Caucasians. The data extracted from HaploReg indicated that ACE I/D polymorphism was not in linkage disequilibrium with other variants in the ACE gene.
The research shows that ACE I/D polymorphism is related to HSPN susceptibility in children.
REFERENCES (21)
1.
Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet 2007; 24: 976-978.
2.
He X, Yu C, Zhao P, et al. The genetics of Henoch-Schonlein purpura: a systematic review and meta-analysis. Rheumatol Int 2013; 33: 1387-1395.
3.
Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90: 916-920.
4.
Shrestha S, Sumingan N, Tan J, et al. Henoch-Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM 2006; 99: 253-265.
5.
Van der Knaap R, Siemes C, Coebergh JWW, et al. Reninangiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism and cancer: the Rotterdam Study. Cancer 2008; 112: 748-757.
6.
Barát E, Böszörményi-Nagy G, Debreczeni LA. Serum angiotensin converting enzyme values in chronic obstructive pulmonary disease. Acta Physiol Hung 1987; 70: 337-342.
7.
Castellon R, Hamdi HK. Demystifying the ACE polymorphism: from genetics to biology. Curr Pharm Des 2007; 13: 1191-1198.
8.
Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin i converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
9.
Yu Y, Liu N, Zeng Q, et al. The efficacy of pregabalin for the management of acute and chronic postoperative pain in thoracotomy: a meta-analysis with trial sequential analysis of randomized-controlled trials. J Pain Res 2018;12: 159-170.
10.
Cui Z, Shi Y, Yin H, et al. Association between angiotensin- converting enzyme gene polymorphism and children with Henoch-Schönlein purpura and Henoch-Schönlein purpura nephritis. China Mod Med 2010; 17: 5-8.
11.
Chang WH, Ji YK, Jeong NL. The effect of angiotensin converting enzyme gene polymorphism in children with Henoch- Schonlein purpura nephritis. J Korean Ped Soc 2002; 45: 884-890.
12.
Yoshioka T, Xu YX, Yoshida H, et al. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child 1998; 79: 394-399.
13.
Nalbantoglu S, Tabel Y, Mir S, et al. Association between RAS gene polymorphisms (ACE I/D, AGT M235T) and Henoch- Schönlein purpura in a Turkish population. Dis Markers 2013; 34: 23-32.
14.
Zhou J, Tian X, Xu Q. Angiotensin-converting enzyme gene insertion/deletion polymorphism in children with Henoch- Schonlein purpua nephritis. Huazhong Univ Sci Technolog Med Sci 2004; 24: 158-161.
15.
Liu D, Lu F, Zhai S, et al. Renin-angiotensin system gene polymorphisms in children with Henoch-Schönlein purpura in West China. J Renin Angiotensin Aldosterone Syst 2010; 11: 248-255.
16.
Ozkaya O, Söylemezoğlu O, Gönen S, et al. Renin-angiotensin system gene polymorphisms: association with susceptibility to Henoch-Schonlein purpura and renal involvement. Clin Rheumatol 2006; 25: 861-865.
17.
Pan Y, Lu H. Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to Kawasaki disease: a meta-analysis. Afr Health Sci 2017; 17: 991-999.
18.
Sprovieri SR, Sens YA. Polymorphisms of the renin-angiotensin system genes in Brazilian patients with lupus nephropathy. Lupus 2005; 14: 356-362. .
19.
Zhang X, Wu L, Chai M, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to Henoch- Schönlein purpura: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2019; 20: 1470320319836302.
20.
Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
21.
Perticone F, Ceravolo R, Maio R, et al. Angiotensin-converting enzyme gene polymorphism is associated with endotheliumdependent vasodilation in never treated hypertensive patients. Hypertension 1998; 31: 900-905.
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
